Betaseron 16-Year Long-Term Follow-Up (LTF) in Patients With Relapsing-Remitting Multiple Sclerosis
NCT00206635
·
clinicaltrials.gov ↗
COMPLETED
Status
432
Enrollment
INDUSTRY
Sponsor class
Conditions
Multiple Sclerosis
Interventions
DRUG:
Interferon beta-1b (Betaseron, BAY86-5046)
Sponsor
Bayer